In addition, the observation that the increase in epithelial ACE2 expression caused by elevated CO2 is reversible suggests that ventilatory support strategies to reduce hypercapnia might also ameliorate SARS-CoV-2 infection and adverse outcomes of COVID-19 in patients with acute or chronic hypercapnic respiratory failure. The gene discussed is ACE2; the disease is COVID-19.